BioLargo (BLGO) Stock Chart & Stock Price History $0.21 -0.01 (-2.47%) As of 05/21/2025 03:21 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock BioLargo Stock Price Performance The BioLargo (BLGO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 28.88%, with a year-to-date return of 10.05%. In the past month, the stock has decreased 8.29%, reflecting recent market activity. As of the latest close, BioLargo traded at $0.21 with a market cap of $63.25 million and volume of 520,278 shares. Five years ago, the stock traded at $0.18, representing a 19.49% increase over that period. At the time, it had a market cap of $24.64 million and a volume of 1.46 million shares. Receive BLGO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioLargo and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.70%1 Month Performance-8.29%3 Month Performance-21.00%Year-To-Date Performance+10.05%1 Year Performance-28.88%5 Year Performance+19.49% BLGO Stock Chart for Thursday, May, 22, 2025 BLGO Chart by TradingView BioLargo Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$0.21$0.21-2.47%$0.21$0.20520,278 shs$63.25 million05/20/2025$0.21$0.21+1.18%$0.21$0.2075,429 shs$64.85 million05/19/2025$0.21$0.21-1.40%$0.21$0.20243,091 shs$64.09 million05/16/2025$0.24$0.21-10.42%$0.23$0.21687,274 shs$64.89 million05/15/2025$0.24$0.24-1.68%$0.24$0.23369,924 shs$72.43 million05/14/2025$0.25$0.24-2.01%$0.26$0.23204,857 shs$73.67 million05/13/2025$0.25$0.25-0.24%$0.26$0.23613,209 shs$75.18 million05/12/2025$0.24$0.25+4.65%$0.25$0.22522,414 shs$75.28 million05/09/2025$0.25$0.24-2.65%$0.25$0.22354,898 shs$71.94 million05/08/2025$0.24$0.25+3.46%$0.25$0.23416,616 shs$73.90 million Get the Latest News and Ratings for BLGO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioLargo and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$0.23$0.24+4.46%$0.24$0.22250,506 shs$71.42 million05/06/2025$0.22$0.23+4.52%$0.23$0.21566,221 shs$68.38 million05/05/2025$0.22$0.22-2.52%$0.25$0.22641,856 shs$65.42 million05/02/2025$0.23$0.22-1.11%$0.23$0.22170,126 shs$67.06 million05/01/2025$0.22$0.23+0.09%$0.24$0.22182,097 shs$67.81 million04/30/2025$0.23$0.22-2.47%$0.23$0.22208,471 shs$67.75 million04/29/2025$0.24$0.23-3.27%$0.24$0.22222,340 shs$69.47 million04/28/2025$0.24$0.24+0.76%$0.24$0.23112,807 shs$71.82 million04/25/2025$0.23$0.24+1.50%$0.24$0.2312,714 shs$71.28 million04/24/2025$0.23$0.23+1.30%$0.24$0.23108,616 shs$70.22 million04/23/2025$0.23$0.23+0.88%$0.23$0.23111,054 shs$69.32 million04/22/2025$0.24$0.23-4.44%$0.24$0.23147,500 shs$68.71 million04/21/2025$0.23$0.24+2.84%$0.24$0.23116,818 shs$71.91 million Related Companies ADUR Stock Chart ARQ Stock Chart ZTEK Stock Chart VGAS Stock Chart ORGN Stock Chart TSE Stock Chart CBUS Stock Chart AMTX Stock Chart ALTO Stock Chart LODE Stock Chart Receive BLGO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioLargo and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BLGO) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump + Musk = AI’s turning pointTrump may not code… but he knows how to pick winners. And according to insiders, his administration is prep...True Market Insiders | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLargo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLargo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.